• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[标记指数作为乳腺癌的预后标志物]

[The labelling index as a prognostic marker in breast carcinoma].

作者信息

Bisail M, Nieddu S, Sarobba M G, Sanna G, Milia V, Ghì M G, Farris A

机构信息

Cattedra di Oncologia Clinica, Università di Sassari.

出版信息

Minerva Med. 1994 Apr;85(4):141-4.

PMID:8028740
Abstract

In this work assess the labelling index in sixty patients affected by breast cancer and treated with only local surgical therapy, without subsequent chemo- or radiotherapy. We had considered L.I. a single prognostic factor and in relation with other common prognostic factors of this neoplasia. The patients with a high L.I. have shown a greater probability of relapses, also in absence of lymph nodal metastases.

摘要

在这项研究中,我们评估了60例仅接受局部手术治疗、未进行后续化疗或放疗的乳腺癌患者的标记指数。我们将标记指数视为单一的预后因素,并将其与该肿瘤的其他常见预后因素相关联。标记指数高的患者复发概率更高,即使在没有淋巴结转移的情况下也是如此。

相似文献

1
[The labelling index as a prognostic marker in breast carcinoma].[标记指数作为乳腺癌的预后标志物]
Minerva Med. 1994 Apr;85(4):141-4.
2
Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.在前哨淋巴结阴性的乳腺癌患者中省略腋窝淋巴结清扫术是安全的:一项长期随访分析。
J Surg Oncol. 2004 Oct 1;88(1):4-7; discussion 7-8. doi: 10.1002/jso.20101.
3
Results of conservative surgery for limited-sized infiltrating breast cancer: analysis of 962 tested patients: 24 years of experience.局限性浸润性乳腺癌保乳手术的结果:962例受试患者的分析:24年经验
J Surg Oncol. 2000 Jun;74(2):108-15. doi: 10.1002/1096-9098(200006)74:2<108::AID-JSO6>3.0.CO;2-Y.
4
Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.乳腺微浸润癌治疗的选择与结果:腋窝淋巴结清扫对T1a和T1b病变治疗的影响
J Am Coll Surg. 1996 Dec;183(6):575-82.
5
[Prognostic factors in operated breast carcinoma].[手术治疗的乳腺癌的预后因素]
Minerva Med. 1995 Jan-Feb;86(1-2):17-20.
6
Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.区分乳腺癌的有利和不利预后标志物:E-钙黏蛋白的作用。
Cancer Res. 2000 Jan 15;60(2):298-304.
7
[Natural history of breast cancer: lobular carcinoma versus ductal carcinoma in our experience].
Ann Ital Chir. 1997 Jan-Feb;68(1):43-7; discussion 48.
8
Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.早期乳腺癌保乳治疗后同侧乳腺肿瘤复发(IBTR):危险因素及对远处转移的影响
Cancer. 2006 Jan 1;106(1):35-41. doi: 10.1002/cncr.21551.
9
Prognostic significance of Ki-67 in chemotherapy-naive breast cancer patients with 10-year follow-up.Ki-67 在 10 年随访的化疗初治乳腺癌患者中的预后意义。
Anticancer Res. 2014 Jan;34(1):259-68.
10
Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast.乳腺浸润性小叶癌的肿块切除术及放射治疗
Am J Surg. 1996 Nov;172(5):496-500. doi: 10.1016/S0002-9610(96)00227-9.